West Pharmaceutical Services' €100M plant underway; Cenexi gets investment;

> The Greek Health Ministry says it has banned the export of 25 types of drugs after receiving warnings by pharmacists that they faced shortages. Story

> Quotient Clinical has bought a 3,000-square-foot manufacturing facility in Nottingham, England, which it expects to have online later this year. Report

> Construction is set to begin next week on the €100 million plant that West Pharmaceutical Services is building in Waterford, Ireland. Story

> Cathay Capital Private Equity has made an unspecified investment in French CDMO Cenexi Group, a 2008 spin-off from Roche ($RHHBY) that is said to have the largest sterile ampoules facility in Europe. Report

> CDMO Almac has opened a regional headquarters in Singapore. Release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.